Latest News and Press Releases
Want to stay updated on the latest news?
-
ZenaTech to Present its Latest Drone Interceptors, Counter-UAS Defense System, ZenaDrone, and Zena AI Developments at Upcoming Investor Conferences and In
-
VANCOUVER, Columbia Británica, March 25, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), proveedor de soluciones tecnológicas especializado en drones...
-
ZenaTech Developing an Integrated Counter-UAS System Pairing the Interceptor P-1 Low-Cost Drone with Zena AI Detection and Swarm Command Software
-
VANCOUVER, Columbia Británica, March 19, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), proveedor de soluciones tecnológicas especializado en drones...
-
ZenaTech’s ZenaDrone Interceptor P-1, Single-Use Autonomous Interceptor Drone, Targeted to Sell for Under $5,000 USD
-
Emerging defense plays are capturing attention as geopolitical tensions drive investment into resilient supply chains, affordable drone defenses, and non-k
-
VANCOUVER, Columbia Británica, March 17, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), proveedor de soluciones tecnológicas especializado en drones...
-
ZenaTech Develops Low-Cost, Single-Use Autonomous Interceptor Drone for ZenaDrone’s Counter-UAS System for US Defense, Middle East, and Ukraine Use
-
ZenaTech Develops Low-Cost, Single-Use Autonomous Interceptor Drone for ZenaDrone’s Counter-UAS System for US Defense, Middle East, and Ukraine Use
-
WALTHAM, Mass., March 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in...